Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Denial and physical outcomes in lung cancer patients, a longitudinal study
Lung Cancer, 06/29/09
Vos MS et al. - Three patterns of denial over time were identified in lung cancer patients: patients displayed either low, moderate or increasing denial. Male lung cancer patients were found to deny at a moderate level more often. A moderate or increasing level of denial was consistently related to improved patient-rated physical outcomes. Lung cancer patients displaying more denial reported a better overall perception of health and better physical functioning. They complained less about fatigue, nausea and vomiting, appetite loss, dysphagia and pain in arm and shoulder than low deniers. Other symptoms did not differ among denial classes.
Related Articles
Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Cancer Causes and Control, 12/03/09
Relevance Score: 71%%
Nutrition Aspects of Lung Cancer
Nutrition in Clinical Practice, 12/03/09
Relevance Score: 71%%
Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)
British Journal of Cancer, 11/30/09
Relevance Score: 70%%
Pathophysiologic Correlation Between 62Cu-ATSM and 18F-FDG in Lung Cancer
The Journal of Nuclear Medicine, 11/17/09
Relevance Score: 70%%
Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab
Journal of Clinical Oncology, 11/12/09
Relevance Score: 70%%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 12/04/09
Phase I Study of Accelerated Conformal Radiotherapy for Stage I Non-Small-Cell Lung Cancer in Patients With Pulmonary Dysfunction: CALGB 39904
Journal of Clinical Oncology, 12/04/09
Nutrition Aspects of Lung Cancer
Nutrition in Clinical Practice, 12/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


